APR 05, 2016 7:06 AM PDT

For Some Osteoporosis, Taking Medications May Be a Mistake

WRITTEN BY: Xuan Pham
A recent study found that treating osteoporosis brought on by hyperparathyroidism with conventional drugs could actually do more harm than help. Instead of taking medicines that seemingly strengthen bones but that are linked to more fractures, the researchers say surgery to remove the overactive parathyroid gland is a more effective alternative.
 
Osteoporosis refers to the loss of calcium from bones, leading to thin and brittle bones that are prone to fracture. The condition is commonly known occur as the body ages normally, but it also occurs as a result of hyperparathyroidism – that is, overactive parathyroid glands. Nearly 400,000 Americans suffer from osteoporosis brought on by their hyperparathyroidism. "Hip fractures, in particular, are associated with significant rates of mortality, disability and loss of independence," said Michael Yeh, an associate professor of surgery and medicine, and first study author.
 
Left: normal bones. Right: bones with osteoporosis

Calcium, the main component that give bones its strength and toughness, is regulated by the parathyroid hormone (PTH), which are released from the parathyroid glands, located in the neck. Normal functioning parathyroids produce PTH when the body is low on calcium, and stops PTH production when calcium levels are sufficient. In hyperparathyroidism, too much hormones over-stimulate the release of calcium from bones into the bloodstream and the subsequent reabsorption by the kidney and intestines. As a result, kidney stones accumulate more in patients with hyperparathyroidism. Moreover, bones quickly lose their calcium reserve and become thin and brittle, prone to fracture.
 
To combat bone loss in hyperparathyroidism, doctors routinely prescribe bisphosphonates, medicines that reduce calcium loss and strengthen bones. These include alendronate (trade name Fosamax) and ibandronate (trade name Boniva). Strangely, though X-rays show increased bone densities from these drugs, doctors didn’t see a corresponding reduction in bone fractures.
 
"Before this study, there was no data that compared parathyroid surgery with prescribing medication on the risk for fractures in people with hyperparathyroidism,” said Yeh. So he and his team set to describe such comparison, using data from over 6,000 people diagnosed with hyperthyroidism over a 10-year span.
 
They found that patients who had surgery to remove the affected parathyroid glands showed the least amount of hip fractures (20 per 1,000 people). People who received no treatment at all for their hyperparathyroidism had the next highest amount of fractures (56 per 1,000 people). The “startling” finding was in the next group: those who were treated bisphosphonates had the highest amount of hip fractures (86 per 1,000 people), which suggests taking the medicine has worse outcomes than if nothing was done at all! The team found the trend persisted when they tallied up all bone fractures of all types.
 
Why would medications that seemingly strengthen bones, as observed in X-rays, show higher incidences of bone fractures? The researchers were also surprised at this finding and can only speculate to the answer. "The drugs make the bones look dense on scans, but that is deceptive," Yeh said. "We must presume there is a defect in the quality of the bone. But we don't know why."
 
"Regardless, we were unable to demonstrate any benefit associated with this class of drugs, which have been around and routinely prescribed for more than 20 years," Yeh concluded. "These findings should make bisphosphonates less attractive as an alternative to parathyroid surgery in patients with primary hyperparathyroidism."
 

Additional source: UCLA press release 
About the Author
I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUN 16, 2022
Cardiology
Height May Be a Risk Factor for Several Conditions
JUN 16, 2022
Height May Be a Risk Factor for Several Conditions
A new study has linked height to a lower risk of coronary heart disease and a higher risk of some circulatory disorders.
JUN 16, 2022
Genetics & Genomics
One in 500 Men Carry an Extra Sex Chromosome
JUN 16, 2022
One in 500 Men Carry an Extra Sex Chromosome
Humans carry 46 chromosomes. We get one from each parent, making 22 pairs of autosomal chromosomes, and one pair of sex ...
JUL 04, 2022
Coronavirus
Some Neurodegenerative Diseases are More Likely After COVID-19
JUL 04, 2022
Some Neurodegenerative Diseases are More Likely After COVID-19
European researchers analyzed the health records of about half the entire population of Denmark, which included 919,731 ...
JUL 25, 2022
Cancer
Does the Secret to Immunotherapy Lie in...Poop?
JUL 25, 2022
Does the Secret to Immunotherapy Lie in...Poop?
Advancements in immunotherapy have proven instrumental in reshaping the face of cancer research in recent years.  W ...
AUG 01, 2022
Cell & Molecular Biology
Gut Microbes that Release Histamine Worsen IBS Pain
AUG 01, 2022
Gut Microbes that Release Histamine Worsen IBS Pain
When the white blood cells in our bodies encounter a pathogen, they can release a molecule called histamine, which can h ...
AUG 04, 2022
Health & Medicine
Parechovirus Infections are Increasing in Infants
AUG 04, 2022
Parechovirus Infections are Increasing in Infants
This year, 29 infants have been admitted to the Children's Hospital at Vanderbilt University Medical Center with human p ...
Loading Comments...